Urn models and vaccine efficacy estimation
✍ Scribed by Carlos M. Hernández-Suárez; Carlos Castillo-Chavez
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 92 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0277-6715
No coin nor oath required. For personal study only.
✦ Synopsis
We derive the distribution of the number of infections among unvaccinated and vaccinated individuals for model 1 (leaky) and model 2 (all/nothing) vaccines, assuming random mixing of a homogeneous population. For all/nothing vaccines, we show that the distribution of the number of infected vaccinated individuals conditioning on n observed infections follows a hypergeometric distribution, and the vaccine e$cacy estimate (VE) can be derived from the usual estimate of the total population size in a capture}recapture sampling program. For leaky vaccines, we show that the number of vaccinated infected follows a distribution that was "rst derived by Wallenius. We found that the current point estimates of VE for each model perform very well, but the urn model construction presented here provides a strong framework for estimation and hypothesis testing on the parameters, and can be applied when the available data are a sample of the population. Since the method does not require an underlying transmission model, it can be applied to estimate the VE for non-contagious diseases.
📜 SIMILAR VOLUMES
Vaccination can have important indirect effects on the spread of an infectious agent by reducing the level of infectiousness of vaccinees who become infected. To estimate the effect of vaccination on infectiousness, one typically requires data on the contacts between susceptible and infected vaccina
It is important to design HIV vaccine trials to estimate the efficacy of a vaccine in reducing infectiousness in addition to the protective efficacy. Currently planned phase III HIV vaccine field trials in which at-risk individuals are randomized and followed over time do not permit estimation or te